Lifecore Biomedical Inc. (LFCR) Stock Analysis

Lifecore Biomedical Inc. (LFCR) is a publicly traded company in the HEALTHCARE sector. It trades at $5.45, carries a market capitalization of $181.92M. This page summarizes the public market data, fundamentals, and frequently asked questions for LFCR, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $5.45
• Market Cap: $181.92M
• EPS: $-1.27
• 52-Week High: $8.98
• 52-Week Low: $3.63

Market Sentiment

Lifecore Biomedical Inc. currently has a Neutral sentiment score of 0.13.

About Lifecore Biomedical Inc.

Lifecore Biomedical Inc. (LFCR) is a leading integrated contract development and manufacturing organization located in Santa Maria, California, renowned for its expertise in formulating and producing complex biopharmaceuticals and medical devices. Leveraging advanced technologies and extensive industry knowledge, the company provides high-quality, tailored solutions to a diverse clientele, both domestically and internationally. Committed to innovation and precision, Lifecore is strategically ...

GNG Research Analysis

GNG Research scores Lifecore Biomedical Inc. (LFCR) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for LFCR.

Frequently Asked Questions

Does LFCR pay dividends?

Lifecore Biomedical Inc. (LFCR) does not currently pay a regular dividend.

What is LFCR's market cap?

Lifecore Biomedical Inc. (LFCR) has a market capitalization of $181.92M with a current stock price of $5.45.